# Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical

> **NCT02573064** · — · COMPLETED · sponsor: **Maimónides Biomedical Research Institute of Córdoba** · enrollment: 113 (actual)

## Conditions studied

- Acinetobacter Infections

## Interventions

- **DRUG:** Colistin
- **DRUG:** Tigecycline
- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT02573064
- **Lead sponsor:** Maimónides Biomedical Research Institute of Córdoba
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02573064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02573064, "Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02573064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*